Patents by Inventor Kirk Van Ness

Kirk Van Ness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN
    Publication number: 20070218523
    Abstract: Modified, furin resistant human TSLP polypeptides and polynucleotides encoding the modified human TSLP polypeptides are provided. Pharmaceutical compositions, B and T cell activation agents, assays and methods of use are also described.
    Type: Application
    Filed: July 23, 2002
    Publication date: September 20, 2007
    Inventors: Stewart Lyman, Kirk Van Ness, Raymond Paxton
  • Methods for increasing polypeptide production
    Publication number: 20050233415
    Abstract: The invention provides methods of increasing the production of polypeptides, optionally recombinant polypeptides, from mammalian cells using xanthine derivatives or hybrid polar compounds and cultures containing the same. Combinations of inducers including a hybrid polar compound and/or a xanthine derivative and/or an alkanoic acid can also be used, optionally at temperatures less than 37° C.
    Type: Application
    Filed: February 4, 2005
    Publication date: October 20, 2005
    Applicant: Immunex Corporation
    Inventors: Kirk Van Ness, Michael Trentalange, Bradley Dell, Jeffrey McGrew